Please try another search
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Ajay Gopal Royan | 43 | 2014 | Independent Director |
Clive A. Meanwell | 66 | 2021 | Independent Director |
Allan Roger Will | 69 | 2012 | Independent Chairman of the Board |
Harith Rajagopalan | 47 | 2010 | Co-Founder, CEO & Director |
Amy W. Schulman | 63 | 2018 | Independent Director |
Samuel Conaway | 59 | 2024 | Independent Director |
William Warren Bradley | 81 | 2017 | Independent Director |
Kelly Barnes | 57 | 2022 | Independent Director |
Marc William Elia | 47 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review